Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering, GSK Reviewing Levitra Promotions After FDA Cites 15-Second TV Ad

This article was originally published in The Pink Sheet Daily

Executive Summary

Commercial for Levitra does not qualify as "reminder ad" because it includes effectiveness claims, agency says in an ad division letter. Acting Commissioner Crawford has expressed a desire to crack down on DTC ads in the erectile dysfunction category. Levitra is one of four products cited by the agency in letters posted over a two-day period.

You may also be interested in...



Late Night Viagra: Pfizer Supports Limiting Hours For Erectile Dysfunction DTC Ads

CEO McKinnell says he agrees with a proposal to limit broadcast commercials for erectile dysfunction agents to the hours of 10 p.m.-6 a.m. PhRMA says it cannot make product-specific recommendations in its forthcoming voluntary DTC guidelines but could urge that ads run at appropriate times to target a drug's indicated population.

Late Night Viagra: Pfizer Supports Limiting Hours For Erectile Dysfunction DTC Ads

CEO McKinnell says he agrees with a proposal to limit broadcast commercials for erectile dysfunction agents to the hours of 10 p.m.-6 a.m. PhRMA says it cannot make product-specific recommendations in its forthcoming voluntary DTC guidelines but could urge that ads run at appropriate times to target a drug's indicated population.

DTC Advertising "Tone-Down" Could Address FDA Concerns, Schering Says

Marketers will begin airing more balanced DTC ads as a result of increased scrutiny from FDA about the quality of some ads, Schering CFO Bertolini says. With Levitra, Schering now participates in what may be a high-risk market for DTC ads: erectile dysfunction disorder.

Related Content

Topics

UsernamePublicRestriction

Register

SC143162

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel